243 related articles for article (PubMed ID: 12725847)
1. Antinociceptive effects of RB101(S), a complete inhibitor of enkephalin-catabolizing enzymes, are enhanced by (+)-HA966, a functional NMDA receptor antagonist: a c-Fos study in the rat spinal cord.
Buritova J; Le Guen S; Fournié-Zaluski MC; Roques BP; Besson JM
Eur J Pain; 2003; 7(3):241-9. PubMed ID: 12725847
[TBL] [Abstract][Full Text] [Related]
2. Antinociceptive effects of RB101, a complete inhibitor of enkephalin-catabolizing enzymes, are enhanced by a cholecystokinin type B receptor antagonist, as revealed by noxiously evoked spinal c-Fos expression in rats.
Honore P; Buritova J; Fournié-Zaluski MC; Roques BP; Besson JM
J Pharmacol Exp Ther; 1997 Apr; 281(1):208-17. PubMed ID: 9103499
[TBL] [Abstract][Full Text] [Related]
3. Further evidence for the interaction of mu- and delta-opioid receptors in the antinociceptive effects of the dual inhibitor of enkephalin catabolism, RB101(S). A spinal c-Fos protein study in the rat under carrageenin inflammation.
Le Guen S; Catheline G; Fournié-Zaluski MC; Roques BP; Besson JM; Buritova J
Brain Res; 2003 Mar; 967(1-2):106-12. PubMed ID: 12650971
[TBL] [Abstract][Full Text] [Related]
4. RB101(S), a dual inhibitor of enkephalinases does not induce antinociceptive tolerance, or cross-tolerance with morphine: a c-Fos study at the spinal level.
Le Guen S; Noble F; Fournié-Zaluski MC; Roques BP; Besson JM; Buritova J
Eur J Pharmacol; 2002 Apr; 441(3):141-50. PubMed ID: 12063085
[TBL] [Abstract][Full Text] [Related]
5. Physiological contributions of neurokinin 1 receptor activation, and interactions with NMDA receptors, to inflammatory-evoked spinal c-Fos expression.
Chapman V; Buritova J; Honoré P; Besson JM
J Neurophysiol; 1996 Sep; 76(3):1817-27. PubMed ID: 8890294
[TBL] [Abstract][Full Text] [Related]
6. The contribution of NMDA receptor activation to spinal c-Fos expression in a model of inflammatory pain.
Chapman V; Honoré P; Buritova J; Besson JM
Br J Pharmacol; 1995 Sep; 116(1):1628-34. PubMed ID: 8564229
[TBL] [Abstract][Full Text] [Related]
7. The effects of RB101, a mixed inhibitor of enkephalin-catabolizing enzymes, on carrageenin-induced spinal c-Fos expression are completely blocked by beta-funaltrexamine, a selective mu-opioid receptor antagonist.
Le Guen S; Honoré P; Catheline G; Fournié-Zaluski MC; Roques BP; Besson JM
Brain Res; 1999 Jul; 834(1-2):200-6. PubMed ID: 10407116
[TBL] [Abstract][Full Text] [Related]
8. Peripheral and/or central effects of racemic-, S(+)- and R(-)-flurbiprofen on inflammatory nociceptive processes: a c-Fos protein study in the rat spinal cord.
Buritova J; Besson JM
Br J Pharmacol; 1998 Sep; 125(1):87-101. PubMed ID: 9776348
[TBL] [Abstract][Full Text] [Related]
9. The antinociceptive effect of combined systemic administration of morphine and the glycine/NMDA receptor antagonist, (+)-HA966 in a rat model of peripheral neuropathy.
Christensen D; Idänpään-Heikkilä JJ; Guilbaud G; Kayser V
Br J Pharmacol; 1998 Dec; 125(8):1641-50. PubMed ID: 9886755
[TBL] [Abstract][Full Text] [Related]
10. Differential contributions of NMDA and non-NMDA receptors to spinal Fos expression evoked by superficial tissue and muscle inflammation in the rat.
Hu JY; Zhao ZQ
Neuroscience; 2001; 106(4):823-31. PubMed ID: 11682167
[TBL] [Abstract][Full Text] [Related]
11. Effects of the potent analgesic enkephalin-catabolizing enzyme inhibitors RB101 and kelatorphan on respiration.
Boudinot E; Morin-Surun M; Foutz AS; Fournié-Zaluski M; Roques BP; Denavit-Saubié M
Pain; 2001 Feb; 90(1-2):7-13. PubMed ID: 11166965
[TBL] [Abstract][Full Text] [Related]
12. Antinociceptive response induced by mixed inhibitors of enkephalin catabolism in peripheral inflammation.
Maldonado R; Valverde O; Turcaud S; Fournié-Zaluski MC; Roques BP
Pain; 1994 Jul; 58(1):77-83. PubMed ID: 7970841
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of the enkephalin-metabolizing enzymes by the first systemically active mixed inhibitor prodrug RB 101 induces potent analgesic responses in mice and rats.
Noble F; Soleilhac JM; Soroca-Lucas E; Turcaud S; Fournie-Zaluski MC; Roques BP
J Pharmacol Exp Ther; 1992 Apr; 261(1):181-90. PubMed ID: 1560364
[TBL] [Abstract][Full Text] [Related]
14. Effects of nefopam on the spinal nociceptive processes: a c-Fos protein study in the rat.
Buritova J; Besson JM
Eur J Pharmacol; 2002 Apr; 441(1-2):67-74. PubMed ID: 12007921
[TBL] [Abstract][Full Text] [Related]
15. Concomitant administration of morphine and an N-methyl-D-aspartate receptor antagonist profoundly reduces inflammatory evoked spinal c-Fos expression.
Honoré P; Chapman V; Buritova J; Besson JM
Anesthesiology; 1996 Jul; 85(1):150-60. PubMed ID: 8694361
[TBL] [Abstract][Full Text] [Related]
16. Effects of intrathecal BAM22 on noxious stimulus-evoked c-fos expression in the rat spinal dorsal horn.
Zeng X; Huang H; Hong Y
Brain Res; 2004 Dec; 1028(2):170-9. PubMed ID: 15527742
[TBL] [Abstract][Full Text] [Related]
17. Excitatory amino acid receptor antagonists and electroacupuncture synergetically inhibit carrageenan-induced behavioral hyperalgesia and spinal fos expression in rats.
Zhang YQ; Ji GC; Wu GC; Zhao ZQ
Pain; 2002 Oct; 99(3):525-535. PubMed ID: 12406529
[TBL] [Abstract][Full Text] [Related]
18. Effects of NMDA receptor antagonists on morphine tolerance: a c-Fos study in the lumbar spinal cord of the rat.
Le Guen S; Catheline G; Besson JM
Eur J Pharmacol; 1999 May; 373(1):1-11. PubMed ID: 10408246
[TBL] [Abstract][Full Text] [Related]
19. Interactions between NMDA- and prostaglandin receptor-mediated events in a model of inflammatory nociception.
Buritova J; Chapman V; Honoré P; Besson JM
Eur J Pharmacol; 1996 May; 303(1-2):91-100. PubMed ID: 8804916
[TBL] [Abstract][Full Text] [Related]
20. Effects of opioids and non-opioids on c-Fos-like immunoreactivity induced in rat lumbar spinal cord neurons by noxious heat stimulation.
Abbadie C; Honoré P; Fournié-Zaluski MC; Roques BP; Besson JM
Eur J Pharmacol; 1994 Jun; 258(3):215-27. PubMed ID: 8088356
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
